Literature DB >> 25166220

Shedding of NG2 by MMP-13 attenuates anoikis.

Nam E Joo1, Di Miao, Mercedes Bermúdez, William B Stallcup, Yvonne L Kapila.   

Abstract

Disruption of cell-matrix interactions can lead to anoikis-apoptosis due to loss of matrix contacts. We previously showed that Nerve/glial antigen 2 (NG2) is a novel anoikis receptor. Specifically, overexpression of NG2 leads to anoikis propagation, whereas its suppression leads to anoikis attenuation. Interestingly, NG2 expression decreases in late anoikis, suggesting that NG2 reduction is also critical to this process. Thus, we hypothesized that NG2 undergoes cleavage to curtail anoikis propagation. Further, since matrix metalloproteinases (MMPs) cleave cell surface receptors, play a major role in modulating apoptosis, and are associated with death receptor cleavage during apoptosis, we further hypothesized that cleavage of NG2 could be mediated by MMPs to regulate anoikis. Indeed, anoikis conditions triggered release of the NG2 extracellular domain into condition media during late apoptosis, and this coincided with increased MMP-13 expression. Treatment with an MMP-13 inhibitor and MMP-13 siRNA increased anoikis, since these treatments blocked NG2 release. Further, NG2-positive cells exhibited increased anoikis upon MMP-13 inhibition, whereas MMP-13 inhibition did not increase anoikis in NG2-null cells, corroborating that retention of NG2 on the cell membrane is critical for sustaining anoikis, and its cleavage for mediating anoikis attenuation. Similarly, NG2 suppression with siRNA inhibited NG2 release and anoikis. In contrast, MMP-13 overexpression or exogenous MMP-13 reduced anoikis by more effectively shedding NG2. In conclusion, maintenance of NG2 on the cell surface promotes anoikis propagation, whereas its shedding by MMP-13 actions attenuates anoikis. Given that these findings are derived in the context of periodontal ligament fibroblasts, these data have implications for periodontal inflammation and periodontal disease pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25166220      PMCID: PMC4248241          DOI: 10.1089/dna.2014.2399

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  55 in total

1.  The proteoglycan NG2 is complexed with alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors by the PDZ glutamate receptor interaction protein (GRIP) in glial progenitor cells. Implications for glial-neuronal signaling.

Authors:  Judith Stegmüller; Hauke Werner; Klaus-Armin Nave; Jacqueline Trotter
Journal:  J Biol Chem       Date:  2002-11-27       Impact factor: 5.157

2.  The shedding of betaglycan is regulated by pervanadate and mediated by membrane type matrix metalloprotease-1.

Authors:  Gabriela Velasco-Loyden; Joaquín Arribas; Fernando López-Casillas
Journal:  J Biol Chem       Date:  2003-12-12       Impact factor: 5.157

3.  Tissue inhibitor of metalloproteinases-3 induces apoptosis in melanoma cells by stabilization of death receptors.

Authors:  Matti Ahonen; Minna Poukkula; Andrew H Baker; Masahide Kashiwagi; Hideaki Nagase; John E Eriksson; Veli-Matti Kähäri
Journal:  Oncogene       Date:  2003-04-10       Impact factor: 9.867

4.  Substrate specificity of human collagenase 3 assessed using a phage-displayed peptide library.

Authors:  S J Deng; D M Bickett; J L Mitchell; M H Lambert; R K Blackburn; H L Carter; J Neugebauer; G Pahel; M P Weiner; M L Moss
Journal:  J Biol Chem       Date:  2000-10-06       Impact factor: 5.157

5.  Fibronectin fragment activation of proline-rich tyrosine kinase PYK2 mediates integrin signals regulating collagenase-3 expression by human chondrocytes through a protein kinase C-dependent pathway.

Authors:  Richard F Loeser; Christopher B Forsyth; Allen M Samarel; Hee-Jeong Im
Journal:  J Biol Chem       Date:  2003-04-30       Impact factor: 5.157

6.  Cleavage of CD95 by matrix metalloproteinase-7 induces apoptosis resistance in tumour cells.

Authors:  Susanne Strand; Petra Vollmer; Lothar van den Abeelen; Daniela Gottfried; Vijay Alla; Hans Heid; Jürgen Kuball; Matthias Theobald; Peter R Galle; Dennis Strand
Journal:  Oncogene       Date:  2004-04-29       Impact factor: 9.867

7.  Matrix metalloproteinase-9 facilitates remyelination in part by processing the inhibitory NG2 proteoglycan.

Authors:  Peter H Larsen; Jennifer E Wells; William B Stallcup; Ghislain Opdenakker; V Wee Yong
Journal:  J Neurosci       Date:  2003-12-03       Impact factor: 6.167

8.  NG2 proteoglycan promotes endothelial cell motility and angiogenesis via engagement of galectin-3 and alpha3beta1 integrin.

Authors:  Jun-ichi Fukushi; Irwan T Makagiansar; William B Stallcup
Journal:  Mol Biol Cell       Date:  2004-06-04       Impact factor: 4.138

9.  Specific pro-apoptotic fibronectin fragments modulate proteinase expression in periodontal ligament cells.

Authors:  Sang-Wook Jee; Shaohui Wang; Yvonne L Kapila
Journal:  J Periodontol       Date:  2004-04       Impact factor: 6.993

10.  The primary structure of NG2, a novel membrane-spanning proteoglycan.

Authors:  A Nishiyama; K J Dahlin; J T Prince; S R Johnstone; W B Stallcup
Journal:  J Cell Biol       Date:  1991-07       Impact factor: 10.539

View more
  12 in total

1.  Cell surface chondroitin sulphate proteoglycan 4 (CSPG4) binds to the basement membrane heparan sulphate proteoglycan, perlecan, and is involved in cell adhesion.

Authors:  Fengying Tang; Megan S Lord; William B Stallcup; John M Whitelock
Journal:  J Biochem       Date:  2018-05-01       Impact factor: 3.387

2.  Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.

Authors:  Le-Le Lu; Jing Sun; Jie-Juan Lai; Yan Jiang; Lian-Hua Bai; Lei-Da Zhang
Journal:  World J Gastroenterol       Date:  2015-06-07       Impact factor: 5.742

Review 3.  Extracellular Matrix in Neural Plasticity and Regeneration.

Authors:  Yurii A Chelyshev; Ilyas M Kabdesh; Yana O Mukhamedshina
Journal:  Cell Mol Neurobiol       Date:  2020-10-31       Impact factor: 5.046

Review 4.  Proteolysis: a key post-translational modification regulating proteoglycans.

Authors:  Timothy J Mead; Sumit Bhutada; Daniel R Martin; Suneel S Apte
Journal:  Am J Physiol Cell Physiol       Date:  2022-07-04       Impact factor: 5.282

5.  Functional roles of CSPG4/NG2 in chondrosarcoma.

Authors:  Nuor S M Jamil; Asim Azfer; Harrison Worrell; Donald M Salter
Journal:  Int J Exp Pathol       Date:  2016-06-12       Impact factor: 1.925

Review 6.  Apoptosis, autophagy, necroptosis, and cancer metastasis.

Authors:  Zhenyi Su; Zuozhang Yang; Yongqing Xu; Yongbin Chen; Qiang Yu
Journal:  Mol Cancer       Date:  2015-02-21       Impact factor: 27.401

Review 7.  NG2 Proteoglycan Enhances Brain Tumor Progression by Promoting Beta-1 Integrin Activation in both Cis and Trans Orientations.

Authors:  William B Stallcup
Journal:  Cancers (Basel)       Date:  2017-03-31       Impact factor: 6.639

Review 8.  Matrix Metalloproteinases as Regulators of Periodontal Inflammation.

Authors:  Cavalla Franco; Hernández-Ríos Patricia; Sorsa Timo; Biguetti Claudia; Hernández Marcela
Journal:  Int J Mol Sci       Date:  2017-02-17       Impact factor: 5.923

9.  The NG2 Proteoglycan Protects Oligodendrocyte Precursor Cells against Oxidative Stress via Interaction with OMI/HtrA2.

Authors:  Frank Maus; Dominik Sakry; Fabien Binamé; Khalad Karram; Krishnaraj Rajalingam; Colin Watts; Richard Heywood; Rejko Krüger; Judith Stegmüller; Hauke B Werner; Klaus-Armin Nave; Eva-Maria Krämer-Albers; Jacqueline Trotter
Journal:  PLoS One       Date:  2015-09-04       Impact factor: 3.240

10.  Effects of chondroitin sulfate proteoglycan 4 (NG2/CSPG4) on soft-tissue sarcoma growth depend on tumor developmental stage.

Authors:  Shu-Hsuan Claire Hsu; Puviindran Nadesan; Vijitha Puviindran; William B Stallcup; David G Kirsch; Benjamin A Alman
Journal:  J Biol Chem       Date:  2017-12-01       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.